#metastaticbreastcancer — Public Fediverse posts

https://www.europesays.com/ie/726768/ Metastatic breast cancer: A rapidly changing treatment landscape #BreastCancer #BreastCancerAwarenessMonth #cancer #Éire #ESMO #Health #IE #Ireland #MetastaticBreastCancer #radiology #Women'sHealth

https://www.europesays.com/ch/141719/ Roche’s giredestrant combination significantly improved progression-free survival in ER-positive advanced breast cancer in phase III evERA data published in The New England Journal of Medicine #BreastCancer #cancer #combination #DiseaseProgression #EndocrineTherapy #MetastaticBreastCancer #OestrogenReceptor #Roche

AstraZeneca and Daiichi Sankyo’s Breast Cancer Drug Approved for NHS Use in England

AstraZeneca PLC (NYSE:AZN) and Daiichi Sankyo’s Enhertu has been cleared for use by England’s National Health Service (NHS)…
#EuropeSays #Britain #Europe #EU #AstraZeneca #AstraZenecaPLC #breAstcancer #DaiichiSankyo #England #incrementalrevenue #metastaticbreastcancer
https://www.europesays.com/britain/128910/

https://www.europesays.com/britain/128910/ AstraZeneca and Daiichi Sankyo’s Breast Cancer Drug Approved for NHS Use in England #AstraZeneca #AstraZenecaPLC #BreAstCancer #DaiichiSankyo #England #IncrementalRevenue #MetastaticBreastCancer

https://www.europesays.com/britain/126192/ AstraZeneca (AZN) Wins FDA Approval for its Breast Cancer Pill After Regulators Voiced Doubts #AstraZeneca #AstraZenecaPLC #BreAstCancer #DiseaseProgression #FDA #MetastaticBreastCancer #ProgressionFreeSurvival

AstraZeneca-Daiichi breast cancer drug cleared for NHS use in England

LONDON, Sept 17 (Reuters) – AstraZeneca and Daiichi Sankyo said on Thursday their breast cancer treatment Enhertu has…
#EuropeSays #Britain #Europe #EU #AstraZeneca #breAstcancer #breastcancertreatment #DaiichiSankyo #Drugprices #England #metastaticbreastcancer #theNationalInstituteforHealthandCareExcellence #UK
https://www.europesays.com/britain/126014/

https://www.europesays.com/britain/126014/ AstraZeneca-Daiichi breast cancer drug cleared for NHS use in England #AstraZeneca #BreAstCancer #BreastCancerTreatment #DaiichiSankyo #DrugPrices #England #MetastaticBreastCancer #TheNationalInstituteForHealthAndCareExcellence #UK

European Commission Expands Role of Gilead’s Trodelvy® in First-Line Metastatic Triple-Negative Breast Cancer Across PD-L1 Status

– European Approval Received for Trodelvy plus Pembrolizumab in First-Line PD-L1-Positive Metastatic Triple-Negative Breast Cancer (TNB…
#Europe #EU #adultpatients #breastcancer #EuropeanUnion #GileadSciences #metastaticbreastcancer #metastaticdisease #systemictherapy #treatmentoption #treatmentoptions #Trodelvy #unresectable
https://www.europesays.com/europe/122410/

https://www.europesays.com/ch/112128/ Roche (SWX:ROP) Starts Breast Cancer Trial With Evexta Bio Using Two Drug Candidates #BreastCancer #ClinicalCollaboration #IndividualInvestors #MetastaticBreastCancer #Roche #RocheHolding

EU Clears AZN’s Etcamah Combo for First-Line ER-Positive Breast Cancer

AstraZeneca AZN announced that the European Commission (EC) has approved Etcamah (camizestrant) in combination with a CDK4/6 inhibitor for…
#EuropeSays #Britain #Europe #EU #AstraZeneca #breAstcancer #combination #inhibitor #metastaticbreastcancer #ZacksInvestmentResearch
https://www.europesays.com/britain/89785/

https://www.europesays.com/britain/89785/ EU Clears AZN’s Etcamah Combo for First-Line ER-Positive Breast Cancer #AstraZeneca #BreAstCancer #combination #inhibitor #MetastaticBreastCancer #ZacksInvestmentResearch

AstraZeneca, Daiichi near UK pricing deal for breast cancer drug, Bloomberg News reports

July 8 (Reuters) – Drugmakers AstraZeneca and Daiichi Sankyo are nearing an agreement with the UK’s pricing regulator…
#EuropeSays #Britain #Europe #EU #AstraZeneca #BloombergNews #breastcancertreatment #DaiichiSankyo #metastaticbreastcancer #NationalHealthService #NHSEngland
https://www.europesays.com/britain/81998/

https://www.europesays.com/britain/81998/ AstraZeneca, Daiichi near UK pricing deal for breast cancer drug, Bloomberg News reports #AstraZeneca #BloombergNews #BreastCancerTreatment #DaiichiSankyo #MetastaticBreastCancer #NationalHealthService #NHSEngland

https://www.europesays.com/ie/550136/ BeOne Medicines (ONC): Citizens Sees an Inflection Point in Its Cancer Pipeline #AmericanSocietyOfClinicalOncology #BeOne #BispecificAntibody #BreastCancer #citizens #Éire #Health #IE #Ireland #LiverCancer #Medication #MetastaticBreastCancer #ONC #OvarianCancer

BeOne Medicines (ONC): Citizens Sees an Inflection Point in Its Cancer Pipeline

BeOne Medicines AG (NASDAQ:ONC) is one of the most promising healthcare stocks according to Wall Street analysts. On…
#NewsBeep #News #Medication #AmericanSocietyofClinicalOncology #AU #Australia #BeOne #bispecificantibody #BreastCancer #citizens #Health #LiverCancer #metastaticbreastcancer #ONC #OvarianCancer
https://www.newsbeep.com/au/755025/

BeOne Medicines (ONC): Citizens Sees an Inflection Point in Its Cancer Pipeline

BeOne Medicines AG (NASDAQ:ONC) is one of the most promising healthcare stocks according to Wall Street analysts. On…
#NewsBeep #News #US #USA #UnitedStates #UnitedStatesOfAmerica #Medication #AmericanSocietyofClinicalOncology #BeOne #bispecificantibody #breastcancer #citizens #Health #Livercancer #metastaticbreastcancer #ONC #ovariancancer
https://www.newsbeep.com/us/720763/

BeOne Medicines (ONC): Citizens Sees an Inflection Point in Its Cancer Pipeline

BeOne Medicines AG (NASDAQ:ONC) is one of the most promising healthcare stocks according to Wall Street analysts. On…
#NewsBeep #News #Medication #AmericanSocietyofClinicalOncology #BeOne #bispecificantibody #breastcancer #CA #Canada #citizens #Health #livercancer #metastaticbreastcancer #ONC #OvarianCancer
https://www.newsbeep.com/ca/755213/

https://www.europesays.com/ch/89170/ Novartis to Acquire Synnovation Therapeutics’ Pan-Mutant Selective PI3Kα Inhibitor Program #DefinitiveAgreement #DevelopmentCapabilities #MetastaticBreastCancer #Novartis #PI3K #Synnovation

https://www.europesays.com/britain/61341/ AstraZeneca Gets CDSCO Approval for Trastuzumab Deruxtecan in HER2-Positive Breast Cancer #AstraZeneca #AstraZenecaIndia #BreastCancerTreatment #CDSCOApproval #CDSCOIndia #DESTINYBreast09Trial #FirstLineTherapy #HER2PositiveBreastCancer #InnovativeTherapy #MetastaticBreastCancer #OncologyApproval #Pertuzumab #PraveenRaoAkkinepally #ProgressionFreeSurvival #TrastuzumabDeruxtecan

https://www.europesays.com/britain/55399/ Can AstraZeneca’s Expanding Cancer Portfolio Sustain Momentum? #AstraZeneca #BreAstCancer #MetastaticBreastCancer #OncologySales

Olema Oncology Announces Clinical Trial Collaboration and Supply Agreement with Bayer to Evaluate OP-3136 in Combination with NUBEQA® (darolutamide) in Metastatic Castration-Resistant Prostate Cancer

Olema Oncology Study to…
#Germany #DE #Europe #EU #Europa #Bayer #AmericanSocietyofClinicalOncology #BayerAG #biopharmaceuticalcompany #Breastcancer #clinicaloutcomes #Combination #metastaticbreastcancer #noveltherapies #Olema #OlemaOncology #prostatecancer
https://www.europesays.com/germany/26214/

https://www.europesays.com/ch/73071/ Novartis advances RLT innovation and reinforces leadership in prostate cancer, breast cancer and hematology with new data at ASCO and EHA #AbstractNumber #AmericanSocietyOfClinicalOncology #BreastCancer #ChronicPhase #MetastaticBreastCancer #Novartis #patients #PresentationDetails #RadioligandTherapy #RLT #TyrosineKinaseInhibitors

https://www.europesays.com/ch/71455/ Roche to present new data at ASCO 2026, reinforcing giredestrant’s potential to transform the treatment paradigm in early breast cancer #ASCO #BreastCancer #cancer #EndocrineTherapy #GastrointestinalCancer #LungCancer #MetastaticBreastCancer #Roche

https://www.europesays.com/ch/71228/ Roche to present new data at ASCO 2026, reinforcing giredestrant’s potential to transform the treatment paradigm in early breast cancer #ASCO #BreastCancer #cancer #EndocrineTherapy #GastrointestinalCancer #LungCancer #MetastaticBreastCancer #Roche

https://www.europesays.com/ch/69473/ Novartis advances RLT innovation and reinforces leadership in prostate cancer, breast cancer and hematology with new data at ASCO and EHA #AbstractNumber #AmericanSocietyOfClinicalOncology #BreastCancer #ChronicPhase #MetastaticBreastCancer #Novartis #patients #PresentationDetails #RadioligandTherapy #RLT #TyrosineKinaseInhibitors

https://www.europesays.com/britain/43074/ How VEPPANU Approval Frames Expectations For AstraZeneca’s Camizestrant In ESR1 Disease #AstraZeneca #BreAstCancer #Camizestrant #HormoneReceptor #MetastaticBreastCancer #PROTAC #VEPPANU

https://www.europesays.com/ch/29414/ Roche’s Breast Cancer Drug Falls Short In Phase 3 Study #BreastCancer #lidERA #MetastaticBreastCancer #Roche #RocheHoldings

https://www.europesays.com/ch/29404/ Roche’s Breast Cancer Drug Falls Short In Phase 3 Study #BreastCancer #lidERA #MetastaticBreastCancer #Roche #RocheHoldings

https://www.europesays.com/ch/28725/ [Ad hoc announcement pursuant to Art. 53 LR] Roche provides update on phase III persevERA study in ER-positive advanced breast cancer #BreastCancer #cancer #EndocrineTherapy #MetastaticBreastCancer #OestrogenReceptor #PhaseIII #Roche

https://www.europesays.com/ch/28566/ Roche’s Giredestrant Misses Key Goal in First-Line Breast Cancer Study #BreastCancer #combination #EstrogenReceptor #MetastaticBreastCancer #palbociclib #PhaseIII #Roche #ZacksInvestmentResearch

https://www.europesays.com/ch/28375/ Roche’s Giredestrant Misses Key Goal in First-Line Breast Cancer Study #BreastCancer #combination #EstrogenReceptor #MetastaticBreastCancer #palbociclib #PhaseIII #Roche #ZacksInvestmentResearch

Respiratory viral infections awaken metastatic breast cancer cells in lungs.

#Virology #RespiratoryViruses #MetastaticBreastCancer #DormantDisseminatedCancerCells #Inluenza #SARS-CoV-2 #COVID19 #Interleukin6 #Mice

https://www.nature.com/articles/s41586-025-09332-0

#TumorBoardTuesday

🔬🧬@DrTeplinksy took us through paradigm-shifting therapy in #HER2 low #metastaticbreastcancer.

➡️Here’s the Case 🎀

👉 🆓 #CME credit by answering 2 quick ❓
ALL CME 🔗: http://integrityce.com/tbt

CME eval🔗: http://integrityce.com/tbteval